MRI Interventions, Inc. announced that its Board of Directors has elected veteran medical device executive Maria Sainz as its newest director. Ms. Sainz's distinguished career in the medical device industry spans over 20 years, and includes 10 years as the top executive for both emerging businesses and large corporate divisions, strong commercial experience bringing therapies to market, significant international experience, and service on both public and private company boards.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | -4.48% |
|
+0.28% | +6.77% |
01/07 | ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 3000E Growth Index | CI |
01/07 | ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell Microcap Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.77% | 21Cr | |
+4.57% | 21TCr | |
+8.61% | 19TCr | |
+26.34% | 16TCr | |
+33.90% | 11TCr | |
+2.17% | 6.55TCr | |
+14.50% | 5.29TCr | |
-3.30% | 4.53TCr | |
-3.98% | 3.97TCr | |
+6.66% | 3.77TCr |
- Stock Market
- Equities
- CLPT Stock
- News ClearPoint Neuro, Inc.
- MRI Interventions, Inc. Elects Maria Sainz as Newest Director